Familial adult myoclonus epilepsy: a pragmatic approach

Ajith Cherian1, K P Divya2, A R Swathy Krishnan1

  • 1Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Medical College P.O, Trivandrum, PIN-695011, Kerala, India.

Acta Neurologica Belgica
|December 20, 2023
PubMed

Insights

Familial Adult Myoclonus Epilepsy (FAME) is a rare, autosomal dominant neurodegenerative disorder. Diagnosis involves specific neurophysiological tests and imaging, revealing cortical origin of tremors and cerebellar changes.

Area of Science:

  • Neurology
  • Genetics
  • Neurodegeneration

Background:

  • Familial Adult Myoclonus Epilepsy (FAME) is a rare autosomal dominant disorder with a prevalence of <1/35,000.
  • Characterized by cortical myoclonic tremor, myoclonus, and occasional tonic-clonic seizures.
  • Considered a slowly progressive neurodegenerative condition.

Purpose of the Study:

  • To summarize the key features, diagnostic methods, and pathological findings of FAME.
  • To differentiate FAME from similar neurological conditions.
  • To highlight the current understanding of FAME's etiology and progression.

Main Methods:

  • Review of existing literature and case reports on FAME.
  • Analysis of diagnostic neurophysiological testing (e.g., jerk-locked back-averaging, evoked potentials).
  • Interpretation of neuroimaging (fMRI) and neuropathology findings (Purkinje cell changes).

Main Results:

  • FAME presents with cortical myoclonic tremor and myoclonus, with seizures being rare.
  • Neurophysiological tests and fMRI suggest a cortical origin for tremors and reduced cerebellar activation.
  • Neuropathology reports indicate cerebellar Purkinje cell changes in affected individuals.

Conclusions:

  • FAME diagnosis relies on characteristic clinical presentation and specific neurophysiological and imaging findings.
  • Differential diagnosis is crucial, distinguishing FAME from essential tremor and other epilepsy syndromes.
  • Current treatment for FAME is primarily symptomatic, underscoring the need for further research.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
372
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
191
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
413
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
184
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K